Quick Answer
CRESCENT BIOPHARMA, INC. reported Revenue (ASC 606) of $10.84 million for fiscal year 2025.
CRESCENT BIOPHARMA, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $10.84M | — |
- The most recent figure is from CRESCENT BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: